Thrombelastography H Reikvam, E Steien, B Hauge, K Liseth, KG Hagen, R Størkson, T Hervig Transfusion and Apheresis Science 40 (2), 119-123, 2009 | 242 | 2009 |
The PI3K-Akt-mTOR signaling pathway in human acute myeloid leukemia (AML) cells I Nepstad, KJ Hatfield, IS Grønningsæter, H Reikvam International journal of molecular sciences 21 (8), 2907, 2020 | 212 | 2020 |
Acute myeloid leukemia with the t (8; 21) translocation: clinical consequences and biological implications H Reikvam, KJ Hatfield, AO Kittang, R Hovland, Ø Bruserud BioMed Research International 2011, 2011 | 156 | 2011 |
The crosstalk between the matrix metalloprotease system and the chemokine network in acute myeloid leukemia K J Hatfield, H Reikvam, O Bruserud Current medicinal chemistry 17 (36), 4448-4461, 2010 | 116 | 2010 |
Hyperferritinemia—a clinical overview M Sandnes, RJ Ulvik, M Vorland, H Reikvam Journal of Clinical Medicine 10 (9), 2008, 2021 | 95 | 2021 |
Therapeutic targeting the cell division cycle 25 (CDC25) phosphatases in human acute myeloid leukemia—the possibility to target several kinases through inhibition of the … AK Brenner, H Reikvam, A Lavecchia, Ø Bruserud Molecules 19 (11), 18414-18447, 2014 | 92 | 2014 |
Venous thromboembolism in patients with essential thrombocythemia and polycythemia vera H Reikvam, RV Tiu Leukemia 26 (4), 563-571, 2012 | 90 | 2012 |
The chemokine network in acute myelogenous leukemia: molecular mechanisms involved in leukemogenesis and therapeutic implications AO Kittang, K Hatfield, K Sand, H Reikvam, Ø Bruserud The Chemokine System in Experimental and Clinical Hematology, 149-172, 2010 | 82 | 2010 |
Febrile neutropenia in acute leukemia. Epidemiology, etiology, pathophysiology and treatment BA Hansen, Ø Wendelbo, Ø Bruserud, AL Hemsing, KA Mosevoll, ... Mediterranean journal of hematology and infectious diseases 12 (1), 2020 | 77 | 2020 |
Heat shock protein 90-a potential target in the treatment of human acute myelogenous leukemia H Reikvam, E Ersvaer, O Bruserud Current cancer drug targets 9 (6), 761-776, 2009 | 74 | 2009 |
The cytokine-mediated crosstalk between primary human acute myeloid cells and mesenchymal stem cells alters the local cytokine network and the global gene expression profile of … H Reikvam, AK Brenner, KM Hagen, K Liseth, S Skrede, KJ Hatfield, ... Stem cell research 15 (3), 530-541, 2015 | 69 | 2015 |
Primary human acute myelogenous leukemia cells release matrix metalloproteases and their inhibitors: release profile and pharmacological modulation H Reikvam, KJ Hatfield, AM Øyan, KH Kalland, AO Kittang, Ø Bruserud European journal of haematology 84 (3), 239-251, 2010 | 66 | 2010 |
Nuclear factor-κB signaling: a contributor in leukemogenesis and a target for pharmacological intervention in human acute myelogenous leukemia H Reikvam, AM Olsnes, BT Gjertsen, E Ersvar, O Bruserud Critical Reviews™ in Oncogenesis 15 (1-2), 2009 | 66 | 2009 |
Cytokines, adhesion molecules, and matrix metalloproteases as predisposing, diagnostic, and prognostic factors in venous thrombosis KA Mosevoll, S Johansen, Ø Wendelbo, I Nepstad, Ø Bruserud, ... Frontiers in medicine 5, 147, 2018 | 65 | 2018 |
Extracorporeal photopheresis (photochemotherapy) in the treatment of acute and chronic graft versus host disease: immunological mechanisms and the results from clinical studies Ø Bruserud, THA Tvedt, PQ Paulsen, AB Ahmed, T Gedde-Dahl, ... Cancer Immunology, Immunotherapy 63, 757-777, 2014 | 61 | 2014 |
The Mirasol® Pathogen Reduction Technology system and quality of platelets stored in platelet additive solution H Reikvam, S Marschner, TO Apelseth, R Goodrich, T Hervig Blood Transfusion 8 (3), 186, 2010 | 58 | 2010 |
Inflammatory mediator profiles differ in sepsis patients with and without bacteremia KA Mosevoll, S Skrede, DL Markussen, HR Fanebust, HK Flaatten, ... Frontiers in Immunology 9, 691, 2018 | 57 | 2018 |
Identification of a subset of patients with acute myeloid leukemia characterized by long-term in vitro proliferation and altered cell cycle regulation of the leukemic cells KJ Hatfield, H Reikvam, Ø Bruserud Expert opinion on therapeutic targets 18 (11), 1237-1251, 2014 | 57 | 2014 |
Expression profile of heat shock proteins in acute myeloid leukaemia patients reveals a distinct signature strongly associated with FLT3 mutation status … H Reikvam, KJ Hatfield, E Ersvaer, R Hovland, J Skavland, BT Gjertsen, ... British journal of haematology 156 (4), 468-480, 2012 | 57 | 2012 |
The angioregulatory cytokine network in human acute myeloid leukemia-from leukemogenesis via remission induction to stem cell transplantation. H Reikvam, KJ Hatfield, H Fredly, I Nepstad, KA Mosevoll, Ø Bruserud European cytokine network 23 (4), 140-153, 2012 | 55 | 2012 |